期刊文献+

HBsAg携带母亲所生婴幼儿HBV标志物动态变化分析 被引量:3

The dynamic changes in serologic HBV markers in infants born by HBsAg-carrying mothers
下载PDF
导出
摘要 目的了解HBsAg携带母亲所生婴幼儿经高效价免疫球蛋白(HBIG)和乙肝疫苗联合免疫后乙肝病毒血清标志物(HBVM)的动态变化及其临床和流行病学意义。方法对209例HBsAg携带母亲的213例婴幼儿(双胎4例)进行随访调查,分别于婴幼儿0、1、4、7、12、24、36月龄应用酶联免疫吸附试验(ELISA)检测其HBVM水平。结果随访婴幼儿182例,随访率达85.45%。婴幼儿出生时HBsAg阳性者13例,随访结束时除2例持续阳性外,余均阴转;出生时HBsAg阴性的169例婴幼儿未出现HBsAg阳转。HBsAg、HBeAg双阳性母亲所生新生儿HBeAg阳性率高达57.69%(30/52)。HBeAg阳性率变化趋势与HBsAg相似,7月龄以后仅2例HBsAg为阳性的婴幼儿HBeAg仍为阳性,余均转阴。HBsAg携带母亲所生婴幼儿出生时抗-HBs阳性率为6.70%(12/179),经HBIG和乙肝疫苗联合免疫后,抗-HBs阳性率1月龄就达82.46%(47/57),7月龄时上升为91.77%(145/158),36月龄维持在73.68%(28/38)。1月龄随访时婴幼儿抗-HBe阳性率为49.12%(28/57),抗-HBc阳性率100%(57/57),之后均逐渐阴转,抗-HBe到24月龄全部阴转;而抗-HBc阳性率7月龄时仍高达84.81%(134/158),到36月龄下降至21.05%(8/38)。结论 HB-sAg携带母亲所生婴幼儿经HBIG和乙肝疫苗联合免疫后免疫效果良好。HBsAg携带母亲血中的HBeAg、抗-HBe和抗-HBc均能通过胎盘从母亲传递给胎儿。 Objective To investigate the dynamic changes in hepatitis B virus serologic markers(HBVM) in infants born by HBsAg-carrying mothers,who were immunized with high-titer immunoglobulin(HTIG) and hepatitis B vaccine,and evaluate the clinical and epidemiological significance thereof.Methods Two hundred and nine HBsAg-carrying pregnant women and their 213 newborns(4 twins) were consecutively involved from Dec.2002 to Oct.2004,and followed up when infants were at 1,7,12,24 and 36 months of age.HBsAg,anti-HBs,HBeAg,anti-HBe and anti-HBc in neonatal sera were detected by ELISA.Results One hundred and eighty-two infants(85.45%) born of HBsAg-positive mothers were followed up.Of them 13 were HBsAg positive at birth.At the end of follow-up,all of them changed negative except two cases who were persistently positive for HBsAg.No one in 169 infants who were HBsAg-negative at birth changed to HBsAg-positive.About 57.69%(30/52) neonates born by both HBsAg and HBeAg positive mothers showed detectable levels of HBeAg.Similar to HBsAg,HBeAg was detectable in only 2 infants who were also HBsAg positive after 7 months of age,and all the other infants became HBeAg-negative.The anti-HBs positive rate of newborn infants of HBsAg-carrying mothers was 6.70%(12/179).After immunizing by HTIG and hepatitis B vaccine,the anti-HBs positive rate reached 82.46%(47/57) at 1 month of age and 91.77%(145/158) at 7 month of age.73.68%(28/38) of infants aged of 36 months showed detectable levels of anti-HBs.The anti-HBe positive rate of infants aged 1 month was 49.12%(28/57),and the anti-HBc positive rate was 100%(57/57).All infants became anti-HBe-negative at age of 24 months.The anti-HBc positive rate was still 84.81%(134/158) at 7 months of age and decreased to 21.05%(8/38) at 36 months of age.Conclusions The efficacy of HTIG combining with hepatitis B vaccine is fine in high risk infants born by HBsAg positive mothers.HBeAg,anti-HBe and anti-HBc can pass through human placenta from mother to fetus passively.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2011年第10期1041-1044,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金资助重点项目(30230320)
关键词 肝炎病毒 乙型 疾病传播 垂直 随访研究 hepatitis B virus disease transmission vertical follow-up studies
  • 相关文献

参考文献9

  • 1王素萍,徐德忠.乙型肝炎病毒宫内感染的研究现状及今后工作重点[J].中华流行病学杂志,2005,26(4):229-231. 被引量:28
  • 2王建设,朱启镕.乙型肝炎表面抗原阳性母亲的婴儿乙型肝炎疫苗单独及与乙型肝炎免疫球蛋白联合免疫后的长期随访研究[J].中国计划免疫,2001,7(2):96-99. 被引量:43
  • 3Shao ZJ, Xu DZ, Xu JQ, et al. Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: A prospective case-control study[J]. Gastroenterol Hepatol, 2007, 22(2):165- 170.
  • 4Stevens CE, Beasley RP, Tsui J, etal. Vertical transmission of hepatitis B antigen in Taiwan[J]. N Engl J Med, 1975, 292(15): 771-774.
  • 5刘一萍,门可,徐德忠,王安辉,徐剑秋,闫永平.乙型肝炎病毒宫内感染的随访研究[J].第四军医大学学报,2004,25(8):734-736. 被引量:13
  • 6Hyams KC. Risks of chronicity following acute hepatitis B virus in fection: a review[J]. Clin Infect Dis, 1995, 20(4):992-1000.
  • 7Arakawa K, Tsuda F, Takahashi K, et al. Maternofetal transmission of IgG-bound hepatitis B e antigen[J]. Pediatr Res, 1982, 16 (3) : 247 -250.
  • 8Chang MH, Hsu HY, Huang LM, et al. The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus[J].J Hepatol, 1996, 24(6): 674- 649.
  • 9Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates[J]. J Viral Hepat, 1999, 6(2) : 135-139.

二级参考文献11

共引文献80

同被引文献43

  • 1张荣莲,陈烈平,陈起燕,王秀云,张丽萍,修晓燕.福建省38418例妊娠期梅毒血清流行病学调查[J].中华流行病学杂志,2007,28(8):749-752. 被引量:13
  • 2Ding F, Yu HG, Li YX, et al. Sequence analysis of the HBV S protein in Chinese patients with coexisting FIBsAg and anti- HBs[J].J Med Virol, 2015, 87(12): 2067 -2073.
  • 3Lada O, Benhamou Y, Poynard T, et al. Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants[J]. J Virol, 2006, 80(6): 2968-2975.
  • 4Yu DM, Li XH, Morn V, et al. N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape[J]. J Hepatol, 2014, 60(3): 515-522.
  • 5Ji D, Liu Y, Si LL, et al. Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patientsJ. Clin Chim Acta, 2011,412(3-4): 305-313.
  • 6Kajiwara E, Tanaka Y, Ohashi T, et al. Hepatitis B caused by a hepatitis B surface antigen escape mutant[J]. J Gastroenterol, 2008, 43(3): 243-247.
  • 7Liu W, Hu T, Wang X, et al. Coexistence of hepatitis B surface antigen and anti-FIBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region[J]. Arch Virol, 2012, 157(4): 627-634.
  • 8Wang L, Liu H, Ning X, et al. Sequence analysis of the S gene region in HBV DNA from patients positive for both HBsAg and HBsAb tests[J]. Hepatol Res, 2010, 40(12): 1212-1218.
  • 9Chen Y, Q ian F, Yuan Q et al. Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs[J]. J Clin ViroI, 2011, 52(3): 198-203.
  • 10Brunetto MR. Chance and necessity of simultaneous HBsAg and anti-HBs detection in the serum of chronic HBsAg carriers[J]. J Fiepatol, 2014, 60(3): 473-475.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部